Heron Therapeutics | HRTX - Ebit





Ebit 変化する 日付
ALKERMES USD 36.59M 102.52M 2026-09
Alnylam Pharmaceuticals USD 179.66M 67.06M 2026-09
Amarin USD -2.26M 564K 2025-12
ANI Pharmaceuticals USD 51.84M 12M 2026-09
Anika Therapeutics USD 646K 3.88M 2025-12
Arrowhead Research USD -154.34M 13.08M 2026-06
Eisai JPY 24.73B 35.04B 2026-06
GlaxoSmithKline GBP 2.86B 251M 2026-09
Heron Therapeutics USD 38K 3.83M 2025-12
Insmed USD -81.83M 19.48M 2026-09
Ligand Pharmaceuticals USD 54.53M 2.1M 2026-09
Merck USD 7.33B 6.49B 2026-09
Nektar Therapeutics USD -38.26M 19.17M 2026-03
Neurocrine Biosciences USD 343M 123.1M 2026-09
Omeros USD -48.15M 7.25M 2023-09
Pacira USD 2.57B 2.56B 2026-09
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Ultragenyx Pharmaceutical USD -110M 35M 2026-09
Veracyte USD 18.02M 5.94M 2026-09
Vertex Pharmaceuticals USD 1.26B 11.3M 2026-09